AKS-452 / Akston 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AKS-452 / Akston
ACT-BOOSTER, NCT05124483: Anti-COVID19 VaccinaTion AKS-452 BOOSTER ( Study)

Recruiting
2
600
Europe
AKS-452X
University Medical Center Groningen, TRACER Europe BV, PRA Health Sciences
COVID-19
07/22
02/23

Download Options